← Back to Screener
STERIS plc (STE)
Price$226.41
Favorite Metrics
Price vs S&P 500 (26W)-13.00%
Price vs S&P 500 (4W)-6.88%
Market Capitalization$22.21B
P/E Ratio (Annual)36.13x
Indicated Dividend Yield (Annual)1.12%
All Metrics
P/CF (Annual)19.34x
Book Value / Share (Quarterly)$72.93
P/TBV (Annual)4.69x
Indicated Dividend (Annual)$2.52
Revenue Growth (3Y)5.99%
Cash Flow / Share (Quarterly)$9.35
Payout Ratio (TTM)33.34%
Price vs S&P 500 (YTD)-15.08%
Gross Margin (TTM)44.11%
Net Profit Margin (TTM)12.14%
EPS (TTM)$7.18
10-Day Avg Trading Volume0.57M
EPS Excl Extra (TTM)$7.18
Revenue Growth (5Y)12.49%
EPS (Annual)$6.20
Dividend / Share (Annual)$2.23
ROI (Annual)7.11%
Gross Margin (Annual)44.01%
Net Profit Margin (5Y Avg)7.78%
Cash / Share (Quarterly)$4.32
P/E Basic Excl Extra (TTM)31.37x
Revenue Growth QoQ (YoY)9.17%
EPS Growth (5Y)5.43%
P/E Normalized (Annual)36.13x
ROA (Last FY)6.06%
Revenue Growth TTM (YoY)7.96%
EBITD / Share (TTM)$14.98
ROE (5Y Avg)6.21%
Operating Margin (TTM)17.03%
Cash Flow / Share (Annual)$7.91
P/B Ratio3.10x
P/B Ratio (Quarterly)3.48x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)4.06x
Net Interest Coverage (TTM)11.23x
ROA (TTM)6.81%
EPS Growth QoQ (YoY)11.49%
EV / EBITDA (TTM)16.02x
EPS Incl Extra (Annual)$6.20
Current Ratio (Annual)1.96x
Quick Ratio (Quarterly)1.53x
3-Month Avg Trading Volume0.75M
52-Week Price Return2.62%
EV / Free Cash Flow (Annual)30.44x
P/E Incl Extra (TTM)31.37x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$55.69
P/S Ratio (Annual)4.07x
Asset Turnover (Annual)0.54x
52-Week High$269.44
Operating Margin (5Y Avg)12.92%
EPS Excl Extra (Annual)$6.20
CapEx CAGR (5Y)11.53%
Tangible BV CAGR (5Y)10.83%
26-Week Price Return-4.26%
Quick Ratio (Annual)1.19x
13-Week Price Return-14.55%
Total Debt / Equity (Annual)0.31x
Current Ratio (Quarterly)2.48x
Enterprise Value$23,679.864
Revenue / Share Growth (5Y)9.25%
Asset Turnover (TTM)0.56x
Book Value / Share Growth (5Y)10.89%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)4.87x
Pretax Margin (Annual)14.58%
Cash / Share (Annual)$1.75
3-Month Return Std Dev28.13%
Gross Margin (5Y Avg)43.59%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)12.96%
EBITDA Interim CAGR (5Y)13.97%
ROE (Last FY)9.31%
Net Interest Coverage (Annual)19.02x
EPS Basic Excl Extra (Annual)$6.20
P/FCF (TTM)24.21x
Receivables Turnover (TTM)6.12x
EV / Free Cash Flow (TTM)25.82x
Total Debt / Equity (Quarterly)0.27x
EPS Incl Extra (TTM)$7.18
Receivables Turnover (Annual)5.32x
ROI (TTM)7.98%
Dividend Growth Rate (5Y)9.04%
P/S Ratio (TTM)3.81x
Pretax Margin (5Y Avg)10.99%
Revenue / Share (Annual)$55.11
Tangible BV / Share (Annual)$48.31
Forward P/E22.20x
Free OCF CAGR (5Y)15.65%
Price vs S&P 500 (52W)-32.47%
P/E Ratio (TTM)31.37x
EPS Growth TTM (YoY)52.18%
Year-to-Date Return-10.94%
5-Day Price Return0.42%
EPS Normalized (Annual)$6.20
ROA (5Y Avg)3.73%
Net Profit Margin (Annual)11.26%
Month-to-Date Return2.11%
Cash Flow / Share (TTM)$11.21
EBITD / Share (Annual)$13.63
EPS Growth (3Y)35.73%
Operating Margin (Annual)16.01%
LT Debt / Equity (Annual)0.29x
P/CF (TTM)17.53x
ROI (5Y Avg)4.40%
P/E Excl Extra (TTM)31.37x
LT Debt / Equity (Quarterly)0.27x
EPS Basic Excl Extra (TTM)$7.18
P/TBV (Quarterly)4.55x
Payout Ratio (Annual)35.77%
P/B Ratio (Annual)3.37x
Dividend / Share (TTM)$2.40
Inventory Turnover (TTM)4.92x
Pretax Margin (TTM)16.13%
Book Value / Share (Annual)$67.18
Price vs S&P 500 (13W)-17.42%
Net Margin Growth (5Y)-3.49%
Dividend Yield (TTM)1.06%
Beta1.00x
P/FCF (Annual)28.54x
Revenue / Share (TTM)$59.11
ROE (TTM)10.21%
52-Week Low$209.98
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.92
3.86
3.86
3.87
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
AVNSAvanos Medical, Inc. | 1.64x | -0.38% | 50.47% | -8.78% | $24.64 |
About
Steris is a global market leader in contract sterilization services for hospitals and medical device manufacturers, with additional revenue from sterilization equipment, washers, and decontamination solutions. The company derives approximately 70% of revenue from healthcare services, 19% from Applied Sterilization Technologies, and 11% from life sciences services, serving care providers and biopharma manufacturers.